[1]
Chandni and N. Kumar Bind, “Risk of malignancy index 4 for differentiating benign from malignant ovarian tumor”, Int J Reprod Contracept Obstet Gynecol, vol. 13, no. 4, pp. 1008–1012, Mar. 2024.